CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
NEW DELHI, March 24, 2026 /PRNewswire/ -- According to the latest research report published by MarkNtel Advisors, the Global Plasma Fractionation Market is projected to grow at a CAGR of around 6.15% ...
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...
Grifols' Board of Directors approves a plan for new industrial investments for the Bioscience Division to ensure the company's long-term sustained growth With these new investments, Grifols increases ...
The Netherlands-based Sanquin Blood Supply Foundation (Stichting Sanquin Bloedvoorziening) inked an agreement to provide Baxter with up to 1.6 million liters of plasma fractionation capacity annually, ...
SK Plasma has officially launched its project to localize plasma fractionation products in Turkey. This business model goes beyond simply exporting finished products, combining the establishment of ...
Grifols plans to upgrade its plasma fractionation plant in Clayton, NC--Courtesy of Grifols Grifols, the Spain-based specialist in blood plasma products, has opened a new plasma fractionation plant in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results